Crossmark

Is TSH suppression still necessary in intermediate- and high-risk papillary thyroid cancer patients with pre-ablation stimulated thyroglobulin <1 ng/mL before the first disease assessment?

Crossref DOI link: https://doi.org/10.1007/s12020-019-01914-z

Published Online: 2019-03-28

Published Print: 2019-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tian, Tian

Huang, Rui

Liu, Bin
License Information

Text and Data Mining valid from 2019-03-28
More Information

Article History

Received: 26 February 2019

Accepted: 19 March 2019

First Online: 28 March 2019

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

: The study was approved by the Institutional Review Board of West China Hospital, Sichuan University and the requirement of written informed consent was waived.

Document is current

Any future updates will be listed below